Literature DB >> 4620428

Hormonal therapies in breast cancer.

B J Kennedy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4620428

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  7 in total

Review 1.  Progesterone and breast cancer.

Authors:  Carol A Lange; Douglas Yee
Journal:  Womens Health (Lond)       Date:  2008-03

Review 2.  Breast cancer. Advances in management.

Authors:  G N Brodie; A Elefanty
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 3.  Evolution of Medical Approaches and Prominent Therapies in Breast Cancer.

Authors:  Suzann Duan; Iain L O Buxton
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575

4.  A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer.

Authors:  J C Allegra; T M Woodcock; S P Richman; K I Bland; J L Wittliff
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

Review 5.  Drug treatment of breast cancer.

Authors:  T E Davis; P P Carbone
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

6.  Randomized clinical trial of tamoxifen plus sequential CMF chemotherapy versus tamoxifen alone in postmenopausal women with advanced breast cancer.

Authors:  J H Glick; R H Creech; S Torri; C Holroyde; H Brodovsky; R B Catalano; M Varano
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

7.  The results of diethylstilboestrol therapy for recurrent and metastatic carcinoma of the male breast.

Authors:  G G Ribeiro
Journal:  Br J Cancer       Date:  1976-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.